Published in Mol Cell Proteomics on June 25, 2003
The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis. Neurochem Res (2006) 1.71
The effects of threonine phosphorylation on the stability and dynamics of the central molecular switch region of 18.5-kDa myelin basic protein. PLoS One (2013) 1.46
Myelin proteomics: molecular anatomy of an insulating sheath. Mol Neurobiol (2009) 1.40
Organellar proteomics reveals Golgi arginine dimethylation. Mol Biol Cell (2004) 1.35
Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation. J Exp Med (2008) 1.34
An N-glucosylated peptide detecting disease-specific autoantibodies, biomarkers of multiple sclerosis. Proc Natl Acad Sci U S A (2005) 1.19
Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous system. Dis Model Mech (2008) 1.14
Deimination of membrane-bound myelin basic protein in multiple sclerosis exposes an immunodominant epitope. Proc Natl Acad Sci U S A (2006) 1.11
Citrullination of histone H3 interferes with HP1-mediated transcriptional repression. PLoS Genet (2012) 1.04
Myelin management by the 18.5-kDa and 21.5-kDa classic myelin basic protein isoforms. J Neurochem (2013) 0.96
Post-translational modifications in the rat lumbar spinal cord in experimental autoimmune encephalomyelitis. J Proteome Res (2007) 0.90
Interaction between the C-terminal region of human myelin basic protein and calmodulin: analysis of complex formation and solution structure. BMC Struct Biol (2008) 0.89
Identification of the low density lipoprotein (LDL) receptor-related protein-1 interactome in central nervous system myelin suggests a role in the clearance of necrotic cell debris. J Biol Chem (2012) 0.89
Backbone dynamics of the 18.5 kDa isoform of myelin basic protein reveals transient alpha-helices and a calmodulin-binding site. Biophys J (2008) 0.88
Multiple sclerosis autoantigen myelin basic protein escapes control by ubiquitination during proteasomal degradation. J Biol Chem (2014) 0.88
Induced secondary structure and polymorphism in an intrinsically disordered structural linker of the CNS: solid-state NMR and FTIR spectroscopy of myelin basic protein bound to actin. Biophys J (2009) 0.84
Phosphopeptide elution times in reversed-phase liquid chromatography. J Chromatogr A (2007) 0.84
Charge isomers of myelin basic protein: structure and interactions with membranes, nucleotide analogues, and calmodulin. PLoS One (2011) 0.83
Immunoenrichment microwave and magnetic proteomics for quantifying CD47 in the experimental autoimmune encephalomyelitis model of multiple sclerosis. Electrophoresis (2012) 0.83
Subcongenic analyses reveal complex interactions between distal chromosome 4 genes controlling diabetogenic B cells and CD4 T cells in nonobese diabetic mice. J Immunol (2012) 0.82
Classic 18.5- and 21.5-kDa myelin basic protein isoforms associate with cytoskeletal and SH3-domain proteins in the immortalized N19-oligodendroglial cell line stimulated by phorbol ester and IGF-1. Neurochem Res (2012) 0.82
Enhanced uptake of multiple sclerosis-derived myelin by THP-1 macrophages and primary human microglia. J Neuroinflammation (2014) 0.81
Partial Immunoblotting of 2D-Gels: A Novel Method to Identify Post-Translationally Modified Proteins Exemplified for the Myelin Acetylome. Proteomes (2017) 0.80
Structured functional domains of myelin basic protein: cross talk between actin polymerization and Ca(2+)-dependent calmodulin interaction. Biophys J (2011) 0.80
Nucleus-localized 21.5-kDa myelin basic protein promotes oligodendrocyte proliferation and enhances neurite outgrowth in coculture, unlike the plasma membrane-associated 18.5-kDa isoform. J Neurosci Res (2012) 0.80
Backbone resonance assignments of the 18.5 kDa isoform of murine myelin basic protein (MBP). J Biomol NMR (2004) 0.80
Copper uptake induces self-assembly of 18.5 kDa myelin basic protein (MBP). Biophys J (2010) 0.79
Myelin basic protein undergoes a broader range of modifications in mammals than in lower vertebrates. J Proteome Res (2012) 0.77
Isoaspartic acid is present at specific sites in myelin basic protein from multiple sclerosis patients: could this represent a trigger for disease onset? Acta Neuropathol Commun (2016) 0.75
Oligodendroglial membrane dynamics in relation to myelin biogenesis. Cell Mol Life Sci (2016) 0.75
An interleukin 1 like factor stimulates bone resorption in vitro. Nature (1984) 3.71
Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanisms. Circulation (1997) 3.38
Isolation of an interleukin-1-like factor from human joint effusions. Arthritis Rheum (1983) 2.75
Stimulation by human interleukin 1 of cartilage breakdown and production of collagenase and proteoglycanase by human chondrocytes but not by human osteoblasts in vitro. Biochim Biophys Acta (1984) 2.00
NMDA receptor encephalitis mimicking seronegative neuromyelitis optica. Neurology (2010) 1.88
Genetic analysis of protein kinase B (AKT) in Drosophila. Curr Biol (1998) 1.85
The four biochemically distinct species of human interleukin 1 all exhibit similar biologic activities. J Immunol (1985) 1.78
Myelin in multiple sclerosis is developmentally immature. J Clin Invest (1994) 1.52
Enhancement of the humoral response of T cell-depleted murine spleens by a factor derived from human monocytes in vitro. J Immunol (1974) 1.49
The isolation and characterization of an acid-soluble protein from myelin. Can J Biochem (1966) 1.49
Immune responses in vitro. X. Functions of macrophages. J Immunol (1974) 1.47
A bicyclic amino acid to improve discriminations among transport systems. J Biol Chem (1969) 1.45
Deimination of myelin basic protein. 1. Effect of deimination of arginyl residues of myelin basic protein on its structure and susceptibility to digestion by cathepsin D. Biochemistry (2000) 1.40
Ribosomal RNA and ribosomes from mitochondria of Neurospora crassa. Proc Natl Acad Sci U S A (1967) 1.40
The adjuvanticity of interleukin 1 in vivo. J Immunol (1983) 1.35
Peptidylarginine deiminase: a candidate factor in demyelinating disease. J Neurochem (2002) 1.31
Stimulation of the proliferation of human bone cells in vitro by human monocyte products with interleukin-1 activity. J Clin Invest (1985) 1.30
The isolation, characterization, and lipid-aggregating properties of a citrulline containing myelin basic protein. J Biol Chem (1989) 1.30
Epidemiology and mortality of burns in Tehran, Iran. Burns (1998) 1.27
Acute multiple sclerosis (Marburg type) is associated with developmentally immature myelin basic protein. Ann Neurol (1996) 1.26
The appearance of transient species of cytochrome c upon rapid oxidation or reduction at alkaline pH. J Biol Chem (1973) 1.26
Release of interleukin-1 from human synovial tissue in vitro. Arthritis Rheum (1985) 1.25
Hybridization of mitochondrial ribosomal RNA. J Mol Biol (1969) 1.23
In vitro activation of human chondrocytes and synoviocytes by a human interleukin-1-like factor. Arthritis Rheum (1984) 1.17
Purification and properties of human B cell-activating factor. J Immunol (1979) 1.17
Mechanisms of bioprosthetic heart valve failure: fatigue causes collagen denaturation and glycosaminoglycan loss. J Biomed Mater Res (1999) 1.15
Interleukin 1 enhances synovial cell hyaluronate synthesis. Proc Soc Exp Biol Med (1984) 1.14
Liquid diffraction analysis of the model membrane system. Egg lecithin + myelin protein (N-2). Biophys J (1979) 1.12
Chromatofocusing nonporous reversed-phase high-performance liquid chromatography/electrospray ionization time-of-flight mass spectrometry of proteins from human breast cancer whole cell lysates: a novel two-dimensional liquid chromatography/mass spectrometry method. Rapid Commun Mass Spectrom (2001) 1.09
Reduction of serum Interleukin-1-like activity after treatment with dexamethasone. J Leukoc Biol (1985) 1.09
Three-dimensional structure of myelin basic protein. II. Molecular modeling and considerations of predicted structures in multiple sclerosis. J Biol Chem (1997) 1.08
Cardiac myoglobin in myoglobinuria. Can Med Assoc J (1966) 1.08
Structural organization of the human myelin membrane. Biochim Biophys Acta (1978) 1.08
Protein-lipid interactions. A nuclear magnetic resonance study of sarcoplasmic reticulum Ca2,Mg2+-ATPase, lipophilin, and proteolipid apoprotein-lecithin systems and a comparison with the effects of cholesterol. Biochemistry (1979) 1.07
Characterization of SDS--PAGE-separated proteins by matrix-assisted laser desorption/ionization mass spectrometry. Anal Chem (1996) 1.07
A novel microtubule independent effect of paclitaxel: the inhibition of peptidylarginine deiminase from bovine brain. Biochim Biophys Acta (1998) 1.06
The folded conformation of the encephalitogenic protein of the human brain. Biochemistry (1974) 1.02
The effects of monocyte-conditioned medium and interleukin 1 on the synthesis of collagenous and non-collagenous proteins by mouse bone and human bone cells in vitro. Biochim Biophys Acta (1984) 1.01
Effect of bovine basic protein charge microheterogeneity on protein-induced aggregation of unilamellar vesicles containing a mixture of acidic and neutral phospholipids. Biochemistry (1985) 1.01
Localization of the CD44 glycoprotein to fibrous astrocytes in normal white matter and to reactive astrocytes in active lesions in multiple sclerosis. J Neuropathol Exp Neurol (1991) 1.01
Hydrophobic and electrostatic interactions of myelin basic proteins with lipid. Participation of N-terminal and C-terminal portions. Biochemistry (1981) 1.00
Isoelectric focusing nonporous RP HPLC: a two-dimensional liquid-phase separation method for mapping of cellular proteins with identification using MALDI-TOF mass spectrometry. Anal Chem (2000) 1.00
Stimulation of the release of a B cell-activating factor from human monocytes. Cell Immunol (1976) 1.00
Rapid profiling of E. coli proteins up to 500 kDa from whole cell lysates using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom (1997) 0.99
Deimination of human myelin basic protein by a peptidylarginine deiminase from bovine brain. J Neurochem (1993) 0.99
Matrix-assisted laser desorption/ionization mass spectrometry of restriction enzyme-digested plasmid DNA using an active Nafion substrate. Rapid Commun Mass Spectrom (1994) 0.98
Isolation of a highly purified myelin protein. Biochemistry (1971) 0.98
Inhibition of aortic wall calcification in bioprosthetic heart valves by ethanol pretreatment: biochemical and biophysical mechanisms. J Biomed Mater Res (1998) 0.98
Solution behavior, circular dichroism and 22 HMz PMR studies of the bovine myelin basic protein. Biochim Biophys Acta (1975) 0.98
Rapid screening of genetic polymorphisms using buccal cell DNA with detection by matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun Mass Spectrom (1995) 0.97
Effect of basic protein from human central nervous system myelin on lipid bilayer structure. J Membr Biol (1978) 0.96
The effect of basic myelin protein on multilayer membrane formation. Biophys J (1981) 0.95
Prevention of calcification of glutaraldehyde-crosslinked porcine aortic cusps by ethanol preincubation: mechanistic studies of protein structure and water-biomaterial relationships. J Biomed Mater Res (1998) 0.95
Three-dimensional structure of myelin basic protein. I. Reconstruction via angular reconstitution of randomly oriented single particles. J Biol Chem (1997) 0.95
Extraction and assay of infectious ribonucleic acid from L cells infected with murine encephalomyocarditis virus. Virology (1965) 0.95
Changes in lipid phase behaviour in human myelin during maturation and aging. Involvement of lipid peroxidation. FEBS Lett (1983) 0.94
The model membrane system. Egg lecithin + myelin protein (N-2). Effect of solvent density variation on the X-ray scattering. Biophys J (1979) 0.94
Carbon-13 "magic-angle" sample-spinning nuclear magnetic resonance studies of human myelin, and model membrane systems. Magn Reson Med (1993) 0.94
Characterization of a recombinant murine 18.5-kDa myelin basic protein. Protein Expr Purif (2000) 0.94
Preparation and properties of vesicles of a purified myelin hydrophobic protein and phospholipid. A spin label study. Biochim Biophys Acta (1976) 0.94
Genetic influences on the adjuvanticity of muramyl dipeptide in vivo. J Immunol (1982) 0.93
Effect of lipid environment on the motion of a spin-label covalently bound to myelin basic protein. Biochemistry (1980) 0.93
Demyelination in a transgenic mouse: a model for multiple sclerosis. J Neurosci Res (1993) 0.93
Identification of three antigens in human brain associated with similar antigens on human leukaemic cells. Biochem J (1985) 0.92
The role of charge microheterogeneity of basic protein in the formation and maintenance of the multilayered structure of myelin: a possible role in multiple sclerosis. J Neurosci Res (1986) 0.92
Resolution of a factor that enhances the antibody response of T cell-depleted murine splenocytes from several other monocyte products. Cell Immunol (1976) 0.92
Phase separation of acidic and neutral phospholipids induced by human myelin basic protein. Biochemistry (1977) 0.91
Rapid release and unusual stability of immunodominant peptide 45-89 from citrullinated myelin basic protein. Biochemistry (1999) 0.90
Paclitaxel (Taxol) attenuates clinical disease in a spontaneously demyelinating transgenic mouse and induces remyelination. Mult Scler (2002) 0.90
Biochemical heterogeneity of human interleukin-1. Lymphokine Res (1985) 0.90
Mouse liver selenium-binding protein decreased in abundance by peroxisome proliferators. Electrophoresis (2000) 0.90
The relationship between bacterial endotoxin and human B cell-activating factor. J Immunol (1978) 0.89
Alteration of lipid-phase behavior in multiple sclerosis myelin revealed by wide-angle x-ray diffraction. Proc Natl Acad Sci U S A (1984) 0.89
The incorporation of L-fucose into glycoproteins in the Golgi apparatus of rat liver and in serum. Biochim Biophys Acta (1973) 0.89
The estimation of gastrin activity in blood. J Physiol (1968) 0.89
Intrinsic fluorescence of a hydrophobic myelin protein and some complexes with phospholipids. Biochemistry (1978) 0.89
The levels of nucleotide-sugar: glycoprotein sialyl- and N-acetylglucosaminyltransferases in normal and pathological human sera. Can J Biochem (1972) 0.89
The developmental expression and activity of peptidylarginine deiminase in the mouse. Neurosci Lett (1999) 0.89
Elevated levels of a glycoprotein antigen (P-80) in gray and white matter of brain from victims of multiple sclerosis. Neurochem Res (1986) 0.88
Highly deiminated isoform of myelin basic protein from multiple sclerosis brain causes fragmentation of lipid vesicles. J Neurosci Res (1999) 0.88
Fourier transform infrared spectroscopic investigation of the interaction between myelin basic protein and dimyristoylphosphatidylglycerol bilayers. Biochemistry (1987) 0.88
Dependence of boundary lipid on fatty acid chain length in phosphatidylcholine vesicles containing a hydrophobic protein from myelin proteolipid. Biochemistry (1978) 0.88
T cells of multiple sclerosis patients target a common environmental peptide that causes encephalitis in mice. J Immunol (2001) 0.87
Cryoelectron microscopy of protein-lipid complexes of human myelin basic protein charge isomers differing in degree of citrullination. J Struct Biol (2000) 0.87
Mechanism of action of human B cell-activating factor. I. Comparison of the plaque-stimulating activity with thymocyte-stimulating activity. J Immunol (1979) 0.87
Use of a nitrocellulose film substrate in matrix-assisted laser desorption/ionization mass spectrometry for DNA mapping and screening. Anal Chem (1995) 0.86
Circular dichroism and proton magnetic resonance studies of random chain poly-L-lysine. Biopolymers (1974) 0.86
Phorbol 12-myristate 13-acetate-induced phosphorylation of Op18 in Jurkat T cells. Identification of phosphorylation sites by matrix-assisted laser desorption ionization mass spectrometry. J Biol Chem (1993) 0.86
Localization of basic proteins in human myelin. J Neurosci Res (1993) 0.86
Effects of development and aging on the concentration of a human brain antigen. Neurosci Lett (1985) 0.86
Lipid phase separation induced by a hydrophobic protein in phosphatidylserine--phosphatidylcholine vesicles. Biochemistry (1977) 0.86